Our observations, combined with previously published reports [4, 15], data such as those in COSMIC, and intriguing individual reports [39, 41], suggest that synonymous mutations in KRAS, and possibly other cancer genes should also be regarded as potential drivers of overexpression and participants in tumorigenesis / transformation. The gene discussed is KRAS; the disease is cancer.